Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

Comment by Montrose9on May 23, 2018 3:34pm
72 Views
Post# 28071380

RE:RE:RE:RE:RE:RE:RE:RE:RE:The split is on the table

RE:RE:RE:RE:RE:RE:RE:RE:RE:The split is on the tablePretty straight forward if you bought 100 shares at 2 dollars and you end up with 1 share that share cost you 200 dollars plus the brokerage. Of course if they do not alter the share structure and the shares go back to 2 dollars then those who buy now are golden. I will be the first to admit I dont enough about this listing to declare it has no value
<< Previous
Bullboard Posts
Next >>